A Medical Device Daily
PortBlue (Los Angeles), a provider of web-based expert systems, reported an agreement with Olympus (Tokyo), a precision technology leader, creating opto-digital solutions in healthcare, life science and consumer electronics products, under which Olympus America (Center Valley, Pennsylvania) will market PortBlue’s PracticeSens medical practice business optimization software to its customers.
The collaboration marks the kickoff of PortBlue’s increased marketing of PracticeSense to ambulatory surgical centers (ASCs) and independent physician groups and practices, among others.
PortBlue says PracticeSense was created in collaboration with experts in the practice management field to analyze data in multiple areas of practice management. PracticeSense provides users with a snapshot of payer contracts analysis, provider compensation, and budgets and expenses, and tracks each of these metrics over time using a dashboard tool. In addition, PracticeSense provides benchmarking of metrics in each of these areas for PHOs, IPAs, larger networks or specialty societies.
Olympus will offer real-time practice analyses – through EndoSite, Olympus’ GI practice and ASC consulting service — and provide solutions to customers to help improve practice performance and operations.
In other agreements news:
• Luminex (Austin, Texas), a multiplex solution developer, reported the signing of a development and supply agreement with Fisher HealthCare (Hampton, New Hampshire), part of Thermo Fisher Scientific (Waltham, Massachusetts). Specific terms of the agreement were not disclosed.
The agreement provides Fisher HealthCare with access to Luminex xMAP-based technology in the U.S. and offers Luminex a new customer sales channel for xMAP-based instruments and assays.
Luminex and Fisher HealthCare said they will jointly identify promising molecular diagnostic applications for Luminex to develop and manufacture on behalf of Fisher HealthCare, taking advantage of the assay multiplexing capabilities of Luminex’s xMAP technology.